Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Wang SY, Zhu S, Wu J, Zhang M, Xu Y, Xu W, et al
GLP-1 receptor agonists were more frequently associated with weight reduction, established atherosclerotic cardiovascular disease, and inadequate glycemic control
doi: 10.1128/aem.53.3.615-617.1987 56 ChoiJAChoSNLimYJLeeJGoDKimSHet al
Some GLP-1 receptor agonists have also demonstrated cardiovascular benefits in clinical trials, though this varies between agents
While health insurance plans do not always provide coverage of Zepbound for weight loss, coverage may be more likely if the drug is prescribed for sleep apnea
Gas-X is the #1 physician recommended product for bloating/gas caused by GLP-1 therapy 1,5,* * Physician recommended claim based on IQVIA survey, 2024
